Alvogen Company Profile

« Back to Dashboard

What is the competitive landscape for ALVOGEN

ALVOGEN has fifty-three approved drugs.

There are two tentative approvals on ALVOGEN drugs.

Summary for Alvogen

US Patents:	0
Tradenames:	43
Ingredients:	41
NDAs:	53
Patent Litigation for Alvogen:	See patent lawsuits for Alvogen
PTAB Cases with Alvogen as petitioner:	See PTAB cases with Alvogen as petitioner

Drugs and US Patents for Alvogen

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	THYRO-TABS	levothyroxine sodium	TABLET;ORAL	021116-005	Oct 24, 2002	AB1,AB2,AB3,AB4	RX	Yes	No
Alvogen	CARBIDOPA	carbidopa	TABLET;ORAL	204291-001	Jan 8, 2016		DISCN	No	No
Alvogen	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	acetaminophen; butalbital; caffeine	TABLET;ORAL	204984-001	Jan 10, 2017		DISCN	No	No
Alvogen	THYRO-TABS	levothyroxine sodium	TABLET;ORAL	021116-011	Oct 24, 2002	AB1,AB2,AB3,AB4	RX	Yes	No
Alvogen	THYRO-TABS	levothyroxine sodium	TABLET;ORAL	021116-004	Oct 24, 2002	AB1,AB2,AB3,AB4	RX	Yes	No
Alvogen	THYRO-TABS	levothyroxine sodium	TABLET;ORAL	021116-010	Oct 24, 2002	AB1,AB2,AB3,AB4	RX	Yes	No

Expired US Patents for Alvogen

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen	LIDEX	fluocinonide	OINTMENT;TOPICAL	016909-002	Approved Prior to Jan 1, 1982	4,017,615
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-003	Aug 1, 1984	4,012,444
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-004	Aug 1, 1984	4,012,444
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-002	Oct 31, 1985	4,642,384
Alvogen	LIDEX	fluocinonide	CREAM;TOPICAL	016908-002	Approved Prior to Jan 1, 1982	3,592,930
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-002	Aug 1, 1984	4,066,755

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Alvogen
• Alvogen Pine Brook